Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Deciphera Pharmaceuticals, LLC
Hans Gelderblom; Vivek Bhadri; Silvia Stacchiotti; Sebastian Bauer; Andrew J Wagner; Michiel van de Sande; Nicholas M Bernthal; Antonio López Pousa; Albiruni Abdul Razak; Antoine Italiano; Mahbubl Ahmed; Axel Le Cesne; Gabriel Tinoco; Kjetil Boye; Javier Martín-Broto; Emanuela Palmerini; Salvatore Tafuto; Sarah Pratap; Benjamin C Powers; Peter Reichardt; Antonio Casado Herráez; Piotr Rutkowski; Christopher Tait; Fiona Zarins; Brooke Harrow; Maitreyi G Sharma; Rodrigo Ruiz-Soto; Matthew L Sherman; Jean-Yves Blay; William D Tap; MOTION investigators